| Metric | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Royalty revenue | $3.0M+19.0% | $2.5M-1.6% | $2.5M |
| Total revenue | $3.0M+19.0% | $2.5M-1.6% | $2.5M |
| Research and development | -$3.1M+6.8% | -$3.3M+5.9% | -$3.5M |
| General and administrative | -$2.7M+19.6% | -$3.4M+4.1% | -$3.6M |
| Total operating costs and expenses | -$5.8M+13.3% | -$6.7M+5.0% | -$7.1M |
| Loss from operations | -$2.8M+32.6% | -$4.2M+6.9% | -$4.5M |
| Other income (expense) | $6K+200.3% | -$6K-122.5% | $25K |
| Interest income, net | $148K-40.8% | $250K-29.8% | $356K |
| Total other income, net | $154K-37.0% | $244K-35.9% | $381K |
| Net loss | -$2.7M+32.3% | -$4.0M+4.2% | -$4.1M |
| Basic net loss per share | -$1.58+38.5% | -$2.57+5.2% | -$2.71 |
| Diluted net loss per share | -$1.58+38.5% | -$2.57+5.2% | -$2.71 |
| Weighted-average shares of common stock outstanding, basic | 1.7M+10.4% | 1.5M+0.9% | 1.5M |
| Weighted-average shares of common stock outstanding, diluted | 1.7M+10.4% | 1.5M+0.9% | 1.5M |
Source: SEC EDGAR XBRL. % change vs prior period shown where available.
Source: SEC EDGAR 10-K and 10-Q filings. Up to 10 years annual / 16 quarters shown.